Medical College of Wisconsin
CTSICores SearchResearch InformaticsREDCap

CURRICULUM VITAE

Anita D'Souza MD
Associate Professor
Department of Medicine
Division of Hematology and Oncology - Medicine

OFFICE ADDRESS:
Clinical Cancer Center
9200 W Wisconsin Ave
Milwaukee, WI 53226
Email: anitadsouza@mcw.edu

EDUCATION:
08/1995 - 11/1999 M.B.B.S., Goa Medical College, Goa, India
01/2000 - 01/2001 Internship, Goa Medical College, Goa, India
04/2001 - 04/2004 M.D., Goa Medical College, Goa, India
09/2013 - 05/2015 M.S., Clinical and Translational Insitiute of Southeast Wisconsin, Milwaukee, WI

POSTGRADUATE TRAINING AND FELLOWSHIP APPOINTMENTS:
01/2000 - 01/2001 Internship, Goa Medical College, Goa, India
04/2001 - 04/2004 M.D., Goa Medical College, Goa, India
07/2007 - 06/2010 Residency, Internal Medicine, William Beaumont Hospital, 4701 West 13 Mile Road, Royal Oak, MI 48073
07/2008 - 08/2008 Hematology/BMT Elective, National Heart, Lung & Blood Institute, Bethesda, MD
07/2010 - 06/2013 Fellowship, Medicine, Hematology/Medical Oncology, Mayo Clinic, 200 First Street SW, Rochester, MN 55905

FACULTY APPOINTMENTS:
09/2013 - 08/2014 Instructor, Medicine, Hematology/Oncology, Medical College of Wisconsin, 9200 West Wisconsin Avenue, Milwaukee, WI 53226
09/01/2014 - Present Assistant Professor, Medicine, Hematology/Oncology, Medical College of Wisconsin, 9200 W Wisconsin Ave, Milwaukee, WI 53226

RESEARCH ADMINISTRATIVE APPOINTMENTS:
05/2006 - 05/2007 Research Fellow, Clupper Lab, Michigan Technologic University, Houghton, MI
09/01/2013 - Present Assistant Scientific Director, Plasma Cell Disorders and Adult Solid Tumors Working Committee, Center for International Blood and Marrow Transplantation (CIBMTR)
09/2013 - Present Member, Hematologic Malignancies and Transplantation, Froedtert and Medical College of Wisconsin Cancer Center, Milwaukee, WI
09/2013 - 09/2014 Research Collaborator, Medicine, Hematology, Mayo Clinic, 200 First Str SW, Rochester, MN 55905

HOSPITAL STAFF PRIVILEGES:
09/2013 - Present Attending Physician, Malignant Hematology and BMT, Froedtert Memorial Lutheran Hospital, 9200 W. Wisconsin Avenue, Milwaukee, WI 53226

SPECIALTY BOARDS AND CERTIFICATION:
Board Certified
Issue DateExpiration
Internal Medicine
08/2010
08/2020
Hematology
11/2013
11/2023
Medical Oncology
11/2013
11/2023
 
Licensure
Number Issue DateExpiration
Michigan
4301090585
07/01/2007
06/30/2010
Minnesota
53303
07/2010
07/2014
Wisconsin
61263-20
09/2013
10/2019
 

AWARDS AND HONORS:
11/1999 First in MBBS, Goa University, Goa, India
2000 Best Medical Graduate, State of Goa, Pfizer Award and Gold Medal
2004 Gold Medal for first in Medicine at the MD, Goa University
2007 - 2008 PGY-1 Resident of the year, Internal Medicine, William Beaumont Hospital, Royal Oak, MI
05/2008 First place, Oral presentation-Case report, ACP Associates Meeting, Michigan
09/2008 Third place, Oral presentation-Case report, Michigan ACP Regional Conference
06/2010 Zimmerman Award for Outstanding clinical judgment, leadership and integrity, William Beaumont Hospital, MI
05/2012 Junior Researcher Travel Award, Amyloidosis Foundation
07/2012 ASBMT Clinical Trials Workshop, American Society of Blood and Marrow Transplantation
08/2012 Fellow Travel Award, Annual Mayo Clinic Hematology/Oncology Reviews, FL
09/2013 - Present Clinical Research Scholar, Center for Translational Science Institute of Southeast Wisconsin (CTSI).
06/2014 - Present Early Career Reviewer Program, National Institute of Health Center for Scientific Review
03/2015 Best Poster Award- Clinical Fellow or Resident (Mentee, Binod Dhakal), 1st Annual Department of Medicine Research Retreat, Medical College of Wisconsin
03/2015 Best Poster Award, Early Career Faculty- Clinical, Population, or Education Research, 1st Annual Department of Medicine Research Retreat, Medical College of Wisconsin
04/2015 Travel Award, Central Society for Clinical and Translational Research
05/2016 Travel Grant, Amyloidosis Foundation
05/2016 - Present Clinical Research Training Institute, American Society of Hematology
2016 - 2017 Mentoring Program, ASH Clinical Research Training Institute
03/2018 NIH Disparities in Multiple Myeloma Think Tank, National Cancer Institute

MEMBERSHIPS IN HONORARY AND PROFESSIONAL SOCIETIES:
07/2007 - Present American Medical Association (Member)
07/2010 - Present American Society of Hematology (Member)
07/2010 - 12/2017 American Society of Clinical Oncology (Member)
04/2011 - Present International Myeloma Foundation (Member)
02/2015 - 02/2016 European Society of Hematology (Member)
04/2016 - Present International Society of Amyloidosis (Member)
03/2018 - Present International Myeloma Working Group (Invited Member)

EDITORSHIPS/EDITORIAL BOARDS/JOURNAL REVIEWS:
Ad-Hoc Reviewer
01/2012 - Present American Journal of Hematology
02/2014 - Present Journal of Proteomics & Bioinformatics
06/2015 - Present American Journal of Nephrology
07/2015 - Present Blood Reviews
08/2015 - Present Biology of Blood and Marrow Transplantation
09/2015 - Present Clinical Chemistry and Laboratory Medicine
11/2015 - Present Bone Marrow Transplantation
03/2016 - Present Leukemia
05/2016 - Present Cancer
07/2016 - Present Journal of Clinical Oncology
07/2016 - Present Amyloid - The Journal of Protein Folding Disorders

NATIONAL ELECTED/APPOINTED LEADERSHIP AND COMMITTEE POSITIONS:
2013 - Present Scientific Director, Plasma Cell Disorders and Adult Solid Tumors, Center for International Blood and Marrow Transplant Research
2014 - Present Early Career Reviewer Program, National Institute of Health Center for Scientific Review
2016 - Present Member, Regimen Related Toxicity and Supportive Care Committee, Blood and Marrow Transplant Clinical Trials Network
03/26/2018 Judge, Poster Session, International Symposium on Amyloidosis, Kumamoto, Japan

RESEARCH GRANTS/AWARDS/CONTRACTS/PROJECTS:
Active
Peer Review
Title:
A Study of Doxycycline Organ Response, and Health-Related Quality of Life in Light Chain Amyloidosis.
Source:
MCW/CTSI
Role:
PI
Dates:
07/01/2016 - 06/30/2019
Direct Funds:
$255,000 (includes 75% salary support)
 
Title:
BMT Clinical Research Network Data Coordinating Center
Source:
NIH/NHLBI
Role:
Co-I
PI:
Mary M Horowitz
Dates:
09/15/2017 - 08/31/2024
Direct Funds:
$45,673,177 (0.6 Cal (Yr 2-3) 2.4 Cal (Yr 4-6) 2.76 Cal (Yr 7))
 
Title:
A Data Resource for Analyzing Blood and Marrow Transplants
Source:
NIH/NCI
Role:
Co-Investigator
PI:
Mary Horowitz
Dates:
09/17/2018 - 02/28/2023
Direct Funds:
$15,441,954
 
Non-Peer Review
Title:
A Phase 1b Study of SAR650984 (Isatuximab) in Combination with Pomalidomide and Dexamethasone for the Treatment of Relapsed/Refractory Multiple Myeloma
Source:
Sanofi US Services, Inc.
Role:
Site PI
Dates:
08/01/2018 - 07/31/2021
Direct Funds:
$77,251 (Per patient enrolled)
 
Title:
Phase ½ Open Label Trial of Tinostamustine Conditioning and Autologous Stem Cell Transplantation for Salvage Treatment in Relapsed/Refractory Multiple Myeloma (Titanium 1) Source: Mundipharma EDO GmbH (Novella Clinical LLC)
Source:
Mundipharma EDO GmbH (Novella Clinical LLC)
Role:
Site PI
Dates:
11/02/2018 - 11/01/2021
Direct Funds:
$12,306 (Per patient enrolled)
 
Pending
Peer Review
Title:
Development and Validation of a Disease-Relevant Patient-Reported Outcome Tool in Light Chain Amyloidosis
Source:
NIH
Role:
PI
Dates:
03/01/2019 - 08/31/2023
Direct Funds:
$554,254
 
Title:
Design and Multi-center Validation of a Risk Model for Allogeneic Transplantation, Combining Objective Biomarkers of Organ Dysfunctions and Patient-Reported Outcomes using Modern Predictive Analytics.
Source:
NIDDK
Role:
Co-I
PI:
Mohammad Sorror
Dates:
04/01/2019 - 03/31/2024
Direct Funds:
$136,270 (Subcontract)
 
Title:
Trajectories and Correlates of Quality of Life (QOL) after Autologous Transplant in Multiple Myeloma
Source:
American Society of Hematology
Dates:
07/01/2019 - 06/30/2021
Direct Funds:
$150,000
 
Title:
A Composite Risk Model Combining Objective Biomarkers, Geriatric Assessment, and Patient-Reported Outcomes for Allogeneic Transplantation.
Source:
NHLBI
Role:
Co-I
PI:
Mohammad Sorror
Dates:
08/01/2019 - 06/30/2024
Direct Funds:
$136,270 (Subcontract)
 
Prior
Peer Review
Title:
Outcomes of light chain amyloidosis with hematopoietic cell transplantation
Source:
Center for International Blood and Marrow Transplant Research
Role:
Principal Investigator
Dates:
09/2013 - 09/2015
 
Title:
Doxycycline as an adjunct to anti-plasma cell chemotherapy in the treatment of light chain amyloidosis
Source:
American Cancer Society Pilot Institutional Research Grant
Role:
Principal Investigator
Dates:
10/01/2014 - 10/31/2016
Direct Funds:
$50,000
 
Non-Peer Review
Title:
A Phase 3, Randomized, Multicenter, Double-Blind, Placebo-Controlled, 2-Arm Efficacy and Saftey Study of NEOD001 Plus Standard of Care vs. Placebo Plus Standard of Care in Subjects with Light Chain (AL) Amyloidosis
Source:
Prothena
Role:
Medical College of Wisconsin Site PI
Dates:
02/01/2015 - 05/30/2018
Direct Funds:
$52,781 (Per patient enrolled)
 
Title:
Phase 2 Multi-center Study of Anti-Programmed-Death-1[anti-PD-1] during Lymphopenic State After High-Dose Chemotherapy and Autologous Hematopoietic Stem Cell Transplant [HDT/ASCT] for Multiple Myeloma
Source:
Merck
Role:
Medical College of Wisconsin Site PI
PI:
Attaphol Pawarode
Dates:
06/01/2015 - 06/30/2015
Direct Funds:
$237,785 (Includes per patient costs, correlative studies and clinical trial office expenses)
 

INVITED LECTURES/WORKSHOPS/PRESENTATIONS:
Local
D'Souza A, POEMS Syndrome: breakthroughs, challenges and future direction., Research talk, Department of Hematology/Oncology, Medical College of Wisconsin, Milwaukee, WI, 11/2012
D'Souza A, Outcomes of Hematopoietic Cell Transplantation in Light Chain Amyloidosis., CTSI Graduate Seminar Presentation, Medical College of Wisconsin, Milwaukee, 03/2015
D’Souza A, New Twists on Light Chain Amyloidosis., Department of Medicine, Hematology/Oncology Research Talk, Medical College of Wisconsin, Milwaukee, WI, 08/2015 - 08/2018
D'Souza A, Unusual Plasma Cell Disorders: When MGUS is of Significance., 13th Annual Multiple Myeloma Survivorship Conference (Leukemia & Lymphoma Society), Pewaukee, WI, 09/12/2015
D'Souza A, Wirk B, Zhang, MJ, Huang J, Krishnan A, Mark T, Gasparetto C, Hari PN, Improved Outcomes of Autologous Hematopoietic Cell Transplantation for Light Chain Amyloidosis: A Center for International Blood and Marrow Transplant Registry (CIBMTR) Study., 1st Annual Department of Medicine Research Retreat, Medical College of Wisconsin, 2015
D'Souza A, Patient-reported outcomes in light chain (AL) amyloidosis., Hematologic Malignancies and Transplantation, Froedtert and Medical College of Wisconsin Cancer Center, 02/11/2016
D'Souza A, Multiple Myeloma., Scientific Lecture at MS-level Statistician’s Workshop, Milwaukee, WI, 04/2017
D'Souza A, Light Chain Amyloidosis: Strategies to Improve Outcomes., Invited Research talk at Clinical and Translational Science Institute of Southeastern Wisconsin, 04/2018
D'Souza A, Patient-Centered Care in Light chain Amyloidosis., Research presentation at PCOR Seminar, 04/2018
 
Regional
D'Souza A, Twists and Turns of Light Chain (AL) Amyloidosis., Fourth Annual Controversies in Hematologic Malignancies Symposium, Milwaukee, 03/07/2015
D'Souza A, Wirk B, Zhang, MJ, Huang J, Krishnan A, Mark T, Gasparetto C, Hari PN, Improved Outcomes of Autologous Hematopoietic Cell Transplantation for Light Chain Amyloidosis: A Center for International Blood and Marrow Transplant Registry (CIBMTR) Study., Central Society for Clinical and Translational Research, Chicago, IL, 2015
Amyloid heart disease: A tale of twisted proteins and broken hearts., Grand Rounds speaker at Greater Milwaukee Heart Failure Society Grand Rounds, Aurora Cardiovascular Services, Milwaukee, WI, 03/22/2016
 
National
D'Souza A, Plasma cell neoplasms- Basics of Multiple Myeloma and Amyloidosis., In Depth Training for Clinical Research Professionals/Data Management. BMT Tandem Meetings, Orlando, FL, 02/23/2017
D'Souza A, Development of Patient-Centered Care in Light Chain Amyloidosis., Invited Research talk at Plasma Cell Disorders Meeting, Perelman Center, University of Pennsylvania, Philadelphia, PA, 01/2018
 
International
D'Souza A, Clinical Outcomes Assessment Use in Rare Disease Studies: Real Life Examples from Patient Advocates, Industry, and Measurement Experts., Symposium presentation at the International Society of Quality of Life 25th Annual Conference, Dublin, Ireland, 10/2018
 

COMMITTEE SERVICE:
Medical College of Wisconsin
07/2015 - Present Member, Hematology/Oncology Fellowship Selection Committee, Hematology/Oncology, Medicine, Medical College of Wisconsin
10/06/2015 Abstract Reviewer and Judge, MCW Research Day
10/2017 - Present Member, Scientific Review Committee, Cancer Center
 

MEDICAL COLLEGE TEACHING ACTIVITIES:
Medical Student Education
01/2014 David Peloza, Grace Clinic
02/2014 Kathleen Hemauer, Grace Clinic
04/2014 Dylan Coss, Grace Clinic
07/2014 Amanda Kraus, Grace Clinic
10/01/2014 - 06/01/2017 Lindsay Hammons, Research Mentor
01/2015 Nick Florence (M4), Grace Clinic
03/2015 Jacob Kohlenberg (M4), Grace Clinic
04/2015 Brad Kimura (M4), Grace Clinic
10/14/2016 - Present Gina Patel, Research Mentor
 
Resident and Fellow Education
11/07/2014 Approach to myeloma in patients eligible for BMT
04/08/2015 Plasma cell dyscrasia
04/10/2015 Transplantation in Plasma Cell Disorders
08/14/2015 Rare plasma cell disorders
 

EXTRAMURAL TEACHING:
Medical Student Education
2014 - Present Froedtert and MCW Clinical Cancer Center, Precept 10-12 medical students at all levels for patients with plasma cell disorders, including assessment, diagnostic work-up and management/year
2015 - 2016 Small Group Facilitator, Physician-Scientist pathway 1-hour core session/month with responsibility for guiding students in clinical research methodology
2015 - Present Blood and Marrow Transplant Attending, Froedtert Hospital, Precept 6-8 medical students at all levels for patients admitted to the BMT Unit including assessment, diagnostic work-up and management/year
 
Resident and Fellow Education
2013 Core Curriculum: Internal Medicine Residency and Hematology/Oncology Fellowship Lecture Series, Approach to myeloma in patients eligible for BMT, Plasma cell dyscrasia, Transplantation in Plasma Cell Disorders, Rare plasma cell disorders
2013 - Present Oncology Attending Physician, Grace Clinic, Froedtert & MCW Clinical Cancer Center, Precept 3-4 fellows at all levels for patients with plasma cell disorders, including assessment, diagnostic work-up and management/year
2013 - Present Oncology and Blood/Marrow Transplant Attending Physician, Froedtert Hospital, Precept 1-2 residents and 3-4 fellows at all levels for patients with malignant hematologic diseases and patients admitted to the BMT Unit including assessment, diagnostic work-up and management/year
 

MCW STUDENTS, FACULTY, RESIDENTS AND CLINICAL/RESEARCH FELLOWS MENTORED:
Medical Students
Lindsay Hammons, Medical College of Wisconsin, 10/01/2014 - 06/01/2017 Research Mentor, Honors in Research Pathway, Abstract #31 presented at the American Society of Clinical Oncology (ASCO) 2016 Annual Meeting, Chicago and MCW Department of Medicine Annual Research Retreat 2016. Oral presentation on Ocular amyloidosis at ACP Wisconsin Chapter Meeting, Wisconsin Dells, WI 09/2016. Original paper #54 on FISH abnormalities in AL amyloidosis. 1/6/2017 Completed thesis and successfully obtained Honors in Research. 03/2017 Accepted into Internal Medicine Residency at Mount Sinai Beth Israel Hospital, New York City, New York.
Gina U Patel, Medical College of Wisconsin, 10/14/2016 - Present Research Mentor, Pathways Project, Status: Working on studying factor X deficiency in AL amyloidosis. Poster selected for 2017 Annual Meeting of the American Society of Hematology (Abstract #38), received Travel Award from MCW Medical School and 2017 ASH Abstract Achievement Award. Original paper #(submitted)
 
Clinical/Research Fellows
Binod Dhakal, Medical College of Wisconsin, 09/2013 - 06/2016, Co-Mentor at 2015 American Society of Blood and Marrow Transplant Clinical Trials Workshop, Committee Member, MS in Clinical and Translational Science Thesis Committee. Publications where I directly mentored/advised him: Abstract #15 (Best Poster Award, 2015 Department of Medicine Research Day), Original Papers: #20, 27, 31, 34. Status: Appointed Assistant Professor of Medicine, MCW (07/2016)
Talha Badar, Medical College of Wisconsin, 07/2017 - Present Clinical Research, Research project studying conditioning regimens in AL amyloidosis. Abstract #47, Original paper # (in revision)
 
Residents
Amara Hussain, Medical College of Wisconsin, 01/01/2014 - 12/2015 Amyloidosis project, Original paper #28, Book chapter #3, #4, 2016 MCWAH Research Award for this work. Accepted for hematology/oncology fellowship at Tufts University, Boston (7/2016).
Nicholas Wright, Medical College of Wisconsin, 02/01/2017 - Present Research Mentor, Project studying distress and quality of life in AL amyloidosis. Poster at International Symposium on Amyloidosis, 2018 and 4th Annual MCW Department of Medicine Research Retreat 2018 (Abstract #50), Original paper #(submitted).
 

EXTRAMURAL STUDENTS, FACULTY, RESIDENTS, AND CLINICAL/RESEARCH FELLOWS MENTORED:
Residents
Ashley O'Reilly, MD, Mayo Clinic, Rochester, MN, 07/01/2012 - 01/01/2013 Mentored ENT resident to work on a case series on amyloidosis; presented as a poster at the Annual Meeting of the American Academy of Otolaryngology and published in a peer reviewed journal
Nicole Gentile, Mayo Clinic, Rochester, MN, 07/01/2012 - 08/01/2012 Mentored first year internal medicine resident to publish a peer-reviewed journal paper on a novel side-effect of ipilimumab.
 

COMMUNITY SERVICE ACTIVITIES:
09/12/2015 Invited Speaker, Unusual Plasma Cell Disorders: When MGUS is of significance, 13th Annual Multiple Myeloma Survivorship Conference (Leukemia & Lymphoma Society), Pewaukee, WI
03/05/2016 Co-Program Director, Fifth Annual Controversies in Hematologic Malignancies Symposium, Milwaukee. This is an annual conference attended by ~200 health care providers from Wisconsin and neighboring states each year.
03/25/2017 - 07/21/2017 Amyloidosis Patient Support Group Meetings. Invited MD to meet with amyloidosis patients and caregivers. Chicago
07/24/2017 - 07/26/2017 Activity Director, Radiation Injury Treatment Network Workshop, Maryland. This is a biennial conference organized by the National Marrow Donor Program/Be The Match and the Medical College of Wisconsin CME Program attended by ~200 health care providers throughout the United States
09/23/2017 Invited Speaker, Blood Cancer Conference, Milwaukee. This is a patient, caregiver and healthcare professionals’ conference, attended by ~260 people from Wisconsin and neighboring areas.
11/18/2017 Invited Speaker, Light chain amyloidosis- What does it have to do with Myeloma? 1st Annual Multiple Myeloma Patient and Caregiver Symposium, Pewaukee, WI
 


BIBLIOGRAPHY
Refereed Journal Publications/Original Papers
1. D'Souza A, Jaiyesimi I, Trainor L, Venuturumili P. Granulocyte colony-stimulating factor administration: adverse events. Transfus Med Rev. 2008 Oct;22(4):280-90.
2. D'Souza A, Wilson J, Mukherjee S, Jaiyesimi I. Progressive multifocal leukoencephalopathy in chronic lymphocytic leukemia: a report of three cases and review of the literature. Clin Lymphoma Myeloma Leuk. 2010 Feb;10(1):E1-9.
3. D'Souza A, Hayman SR, Buadi F, Mauermann M, Lacy MQ, Gertz MA, Kyle RA, Kumar S, Greipp PR, Lust JA, Russell SJ, Zeldenrust S, Dingli D, Witzig TE, Rajkumar SV, Dispenzieri A. The utility of plasma vascular endothelial growth factor levels in the diagnosis and follow-up of patients with POEMS syndrome. Blood. 2011 Oct 27;118(17):4663-5.
4. D'Souza A, Lacy M, Gertz M, Kumar S, Buadi F, Hayman S, Dingli D, Zeldenrust S, Kyle R, Ansell S, Inwards D, Johnston P, Micallef I, Porrata L, Litzow M, Gastineau D, Hogan W, Dispenzieri A. Long-term outcomes after autologous stem cell transplantation for patients with POEMS syndrome (osteosclerotic myeloma): a single-center experience. Blood. 2012 Jul 05;120(1):56-62.
5. D'Souza A, Theis JD, Vrana JA, Buadi F, Dispenzieri A, Dogan A. Localized insulin-derived amyloidosis: a potential pitfall in the diagnosis of systemic amyloidosis by fat aspirate. Am J Hematol. 2012 Nov;87(11):E131-2.
6. D'Souza A, Pardanani A, Tefferi A. Lymphoma-associated versus lymphocytic-variant hypereosinophilia. Leuk Lymphoma. 2012 Nov;53(11):2103-4.
7. Pardanani A, D'Souza A, Knudson RA, Hanson CA, Ketterling RP, Tefferi A. Long-term follow-up of FIP1L1-PDGFRA-mutated patients with eosinophilia: survival and clinical outcome. Leukemia. 2012 Nov;26(11):2439-41.
8. Jaben EA, Jacob EK, Tauscher C, D'Souza A, Hogan WJ, Stubbs JR. Clinically significant anti-A(1) in a presumed ABO-identical hematopoietic stem cell transplant recipient: a case report. Transfusion. 2013 Jan;53(1):202-5.
9. Gentile NM, D'Souza A, Fujii LL, Wu TT, Murray JA. Association between ipilimumab and celiac disease. Mayo Clin Proc. 2013 Apr;88(4):414-7.
10. D'Souza A, Theis J, Quint P, Kyle R, Gertz M, Zeldenrust S, Vrana J, Dogan A, Dispenzieri A. Exploring the amyloid proteome in immunoglobulin-derived lymph node amyloidosis using laser microdissection/tandem mass spectrometry. Am J Hematol. 2013 Jul;88(7):577-80.
11. D'Souza A, Ansell S, Reeder C, Gertz MA. Waldenström macroglobulinaemia: the key questions. Br J Haematol. 2013 Aug;162(3):295-303.
12. O'Reilly A, D'Souza A, Lust J, Price D. Localized tongue amyloidosis: a single institutional case series. Otolaryngol Head Neck Surg. 2013 Aug;149(2):240-4.
13. Keyzner A, D'Souza A, Lacy M, Gertz M, Hayman S, Buadi F, Kumar S, Dingli D, Engebretson A, Tong C, Dispenzieri A. Low levels of interleukin-1 receptor antagonist (IL-1RA) predict engraftment syndrome after autologous stem cell transplantation in POEMS syndrome and other plasma cell neoplasms. Biol Blood Marrow Transplant. 2013 Sep;19(9):1395-8.
14. D'Souza A, Theis JD, Vrana JA, Dogan A. Pharmaceutical amyloidosis associated with subcutaneous insulin and enfuvirtide administration. Amyloid. 2014 Jun;21(2):71-5. PMCID: PMC4021035
15. Dhakal B, Strouse C, D'Souza A, Arce-Lara C, Esselman J, Eastwood D, Pasquini M, Saber W, Drobyski W, Rizzo JD, Hari PN, Hamadani M. Plerixafor and abbreviated-course granulocyte colony-stimulating factor for mobilizing hematopoietic progenitor cells in light chain amyloidosis. Biol Blood Marrow Transplant. 2014 Dec;20(12):1926-31.
16. Dhakal B, Harrington AM, Stadler ME, D'Souza A. Localized lymph node light chain amyloidosis. Case Rep Hematol. 2015;2015:816565. PMCID: PMC4398934
17. D'Souza A, Pasquini M, Spellecy R. Is 'informed consent' an 'understood consent' in hematopoietic cell transplantation? Bone Marrow Transplant. 2015 Jan;50(1):10-4. PMCID: PMC4320584
18. Dhakal B, Singavi A, Cohen EP, Dangal M, Palmer J, Dall A, D'Souza A, Hamadani M, Hari PN. Chronic GVHD and concurrent new-onset nephrotic syndrome in allogeneic transplant recipients. Incidence, pattern and therapeutic outcomes. Bone Marrow Transplant. 2015 Mar;50(3):449-51.
19. Dhakal B, D'Souza A, Arce-Lara C, Pasquini M, Saber W, Falvo F, Esselman J, Zellner K, Fenske T, Hari PN, Hamadani M. Superior efficacy but higher cost of plerixafor and abbreviated-course G-CSF for mobilizing hematopoietic progenitor cells (HPC) in AL amyloidosis. Bone Marrow Transplant. 2015 Apr;50(4):610-2.
20. Karam C, Klein CJ, Dispenzieri A, Dyck PJ, Mandrekar J, D'Souza A, Mauermann ML. Polyneuropathy improvement following autologous stem cell transplantation for POEMS syndrome. Neurology. 2015 May 12;84(19):1981-7. PMCID: PMC4433461
21. Bachanova V, Burns LJ, Ahn KW, Laport GG, Akpek G, Kharfan-Dabaja MA, Nishihori T, Agura E, Armand P, Jaglowski SM, Cairo MS, Cashen AF, Cohen JB, D'Souza A, Freytes CO, Gale RP, Ganguly S, Ghosh N, Holmberg LA, Inwards DJ, Kanate AS, Lazarus HM, Malone AK, Munker R, Mussetti A, Norkin M, Prestidge TD, Rowe JM, Satwani P, Siddiqi T, Stiff PJ, William BM, Wirk B, Maloney DG, Smith SM, Sureda AM, Carreras J, Hamadani M, Center for International Blood and Marrow Transplant Research Lymphoma Working Committee. Impact of Pretransplantation (18)F-fluorodeoxy Glucose-Positron Emission Tomography Status on Outcomes after Allogeneic Hematopoietic Cell Transplantation for Non-Hodgkin Lymphoma. Biol Blood Marrow Transplant. 2015 Sep;21(9):1605-11. PMCID: PMC4558181
22. Abidi MZ, D'Souza A, Kuppalli K, Ledeboer N, Hari P. CYP2C19*17 genetic polymorphism--an uncommon cause of voriconazole treatment failure. Diagn Microbiol Infect Dis. 2015 Sep;83(1):46-8.
23. Laine J, D'Souza A, Siddiqui S, Sayko O, Brazauskas R, Eickmeyer SM. Rehabilitation referrals and outcomes in the early period after hematopoietic cell transplantation. Bone Marrow Transplant. 2015 Oct;50(10):1352-7. PMCID: PMC4598272
24. Hussain AS, Hari P, Brazauskas R, Arce-Lara C, Pasquini M, Hamadani M, D'Souza A. Changes in cardiac biomarkers with bortezomib treatment in patients with advanced cardiac amyloidosis. Am J Hematol. 2015 Nov;90(11):E212-3. PMCID: PMC4618044
25. D'Souza A, Dispenzieri A, Wirk B, Zhang MJ, Huang J, Gertz MA, Kyle RA, Kumar S, Comenzo RL, Peter Gale R, Lazarus HM, Savani BN, Cornell RF, Weiss BM, Vogl DT, Freytes CO, Scott EC, Landau HJ, Moreb JS, Costa LJ, Ramanathan M, Callander NS, Kamble RT, Olsson RF, Ganguly S, Nishihori T, Kindwall-Keller TL, Wood WA, Mark TM, Hari P. Improved Outcomes After Autologous Hematopoietic Cell Transplantation for Light Chain Amyloidosis: A Center for International Blood and Marrow Transplant Research Study. J Clin Oncol. 2015 Nov 10;33(32):3741-9. PMCID: PMC4737858
26. Klyuchnikov E, Bacher U, Kröger NM, Hari PN, Ahn KW, Carreras J, Bachanova V, Bashey A, Cohen JB, D'Souza A, Freytes CO, Gale RP, Ganguly S, Hertzberg MS, Holmberg LA, Kharfan-Dabaja MA, Klein A, Ku GH, Laport GG, Lazarus HM, Miller AM, Mussetti A, Olsson RF, Slavin S, Usmani SZ, Vij R, Wood WA, Maloney DG, Sureda AM, Smith SM, Hamadani M. Reduced-Intensity Allografting as First Transplantation Approach in Relapsed/Refractory Grades One and Two Follicular Lymphoma Provides Improved Outcomes in Long-Term Survivors. Biol Blood Marrow Transplant. 2015 Dec;21(12):2091-2099. PMCID: PMC4639453
27. Uy GL, Costa LJ, Hari PN, Zhang MJ, Huang JX, Anderson KC, Bredeson CN, Callander NS, Cornell RF, Perez MA, Dispenzieri A, Freytes CO, Gale RP, Garfall A, Gertz MA, Gibson J, Hamadani M, Lazarus HM, Kalaycio ME, Kamble RT, Kharfan-Dabaja MA, Krishnan AY, Kumar SK, Kyle RA, Landau HJ, Lee CH, Maiolino A, Marks DI, Mark TM, Munker R, Nishihori T, Olsson RF, Ramanathan M, Rodriguez TE, Saad AA, Savani BN, Schiller GJ, Schouten HC, Schriber JR, Scott E, Seo S, Sharma M, Ganguly S, Stadtmauer EA, Tay J, To LB, Vesole DH, Vogl DT, Wagner JL, Wirk B, Wood WA, D'Souza A. Contribution of chemotherapy mobilization to disease control in multiple myeloma treated with autologous hematopoietic cell transplantation. Bone Marrow Transplant. 2015 Dec;50(12):1513-8. PMCID: PMC4548821
28. Dhakal B, D'Souza A, Pasquini M, Saber W, Fenske TS, Moss RB, Drobyski WR, Hari P, Abidi MZ. DAS181 Treatment of Severe Parainfluenza Virus 3 Pneumonia in Allogeneic Hematopoietic Stem Cell Transplant Recipients Requiring Mechanical Ventilation. Case Rep Med. 2016;2016:8503275. PMCID: PMC4749780
29. Dhakal B, Brazauskas R, Lara CA, Hari P, Pasquini M, D'Souza A. Monocyte recovery at day 100 is associated with improved survival in multiple myeloma patients who undergo allogeneic hematopoietic cell transplantation. Bone Marrow Transplant. 2016 Feb;51(2):297-9. PMCID: PMC4956087
30. Anthias C, Shaw BE, Kiefer DM, Liesveld JL, Yared J, Kamble RT, D'Souza A, Hematti P, Seftel MD, Norkin M, DeFilipp Z, Kasow KA, Abidi MH, Savani BN, Shah NN, Anderlini P, Diaz MA, Malone AK, Halter JP, Lazarus HM, Logan BR, Switzer GE, Pulsipher MA, Confer DL, O'Donnell PV. Significant Improvements in the Practice Patterns of Adult Related Donor Care in US Transplantation Centers. Biol Blood Marrow Transplant. 2016 Mar;22(3):520-7. PMCID: PMC4760616
31. Ramakrishnan V, D'Souza A. Signaling Pathways and Emerging Therapies in Multiple Myeloma. Curr Hematol Malig Rep. 2016 Apr;11(2):156-64.
32. D'Souza A, Huang J, Hari P. New Light Chain Amyloid Response Criteria Help Risk Stratification of Patients by Day 100 after Autologous Hematopoietic Cell Transplantation. Biol Blood Marrow Transplant. 2016 Apr;22(4):768-770. PMCID: PMC4801777
33. Dhakal B, D'Souza A, Martens M, Kapke J, Harrington AM, Pasquini M, Saber W, Drobyski WR, Zhang MJ, Hamadani M, Hari PN. Allogeneic Hematopoietic Cell Transplantation in Multiple Myeloma: Impact of Disease Risk and Post Allograft Minimal Residual Disease on Survival. Clin Lymphoma Myeloma Leuk. 2016 07;16(7):379-86.
34. Fenske TS, Ahn KW, Graff TM, DiGilio A, Bashir Q, Kamble RT, Ayala E, Bacher U, Brammer JE, Cairo M, Chen A, Chen YB, Chhabra S, D'Souza A, Farooq U, Freytes C, Ganguly S, Hertzberg M, Inwards D, Jaglowski S, Kharfan-Dabaja MA, Lazarus HM, Nathan S, Pawarode A, Perales MA, Reddy N, Seo S, Sureda A, Smith SM, Hamadani M. Allogeneic transplantation provides durable remission in a subset of DLBCL patients relapsing after autologous transplantation. Br J Haematol. 2016 07;174(2):235-48. PMCID: PMC4940282
35. Ghosh N, Karmali R, Rocha V, Ahn KW, DiGilio A, Hari PN, Bachanova V, Bacher U, Dahi P, de Lima M, D'Souza A, Fenske TS, Ganguly S, Kharfan-Dabaja MA, Prestidge TD, Savani BN, Smith SM, Sureda AM, Waller EK, Jaglowski S, Herrera AF, Armand P, Salit RB, Wagner-Johnston ND, Fuchs E, Bolaños-Meade J, Hamadani M. Reduced-Intensity Transplantation for Lymphomas Using Haploidentical Related Donors Versus HLA-Matched Sibling Donors: A Center for International Blood and Marrow Transplant Research Analysis. J Clin Oncol. 2016 09 10;34(26):3141-9. PMCID: PMC5012706
36. Dhakal B, Veltri LW, Fenske TS, Eastwood D, Craig MD, Cumpston A, Shillingburg A, Esselman J, Watkins K, Pasquini MC, D'Souza A, Hari P, Kanate AS, Hamadani M. Hematopoietic Progenitor Cell Mobilization with Ifosfamide, Carboplatin, and Etoposide Chemotherapy versus Plerixafor-Based Strategies in Patients with Hodgkin and Non-Hodgkin Lymphoma. Biol Blood Marrow Transplant. 2016 10;22(10):1773-1780.
37. Scott EC, Hari P, Sharma M, Le-Rademacher J, Huang J, Vogl D, Abidi M, Beitinjaneh A, Fung H, Ganguly S, Hildebrandt G, Holmberg L, Kalaycio M, Kumar S, Kyle R, Lazarus H, Lee C, Maziarz RT, Meehan K, Mikhael J, Nishihori T, Ramanathan M, Usmani S, Tay J, Vesole D, Wirk B, Yared J, Savani BN, Gasparetto C, Krishnan A, Mark T, Nieto Y, D'Souza A. Post-Transplant Outcomes in High-Risk Compared with Non-High-Risk Multiple Myeloma: A CIBMTR Analysis. Biol Blood Marrow Transplant. 2016 10;22(10):1893-1899. PMCID: PMC5090978
38. Raj RV, Hari P, Pasquini M, Epperla N, D'Souza A, Fenske T, Shaw BE, Rizzo JD, Drobyski W, Hamadani M. Impact of haploidentical hematopoietic cell transplantation conditioning intensity on the incidence and severity of post-transplantation viral infections. Bone Marrow Transplant. 2016 12;51(12):1602-1604.
39. D’Souza A, Flynn K, Chhabra S, Dhakal B, Hamadani M, Jacobson K, Pasquini M, Weihrauch D, Hari P. . Rationale and Design of DUAL Study: Doxycycline to Upgrade response in light chain (AL) amyloidosis (DUAL): A phase 2 pilot study of a two-pronged approach of prolonged doxycycline with plasma cell-directed therapy in the treatment of AL amyloidosis. Contemporary Clinical Trials Communications. 2017; 8:33-38.
40. Cornell RF, Bachanova V, D'Souza A, Woo-Ahn K, Martens M, Huang J, Al-Homsi AS, Chhabra S, Copelan E, Diaz MA, Freytes CO, Gale RP, Ganguly S, Hamadani M, Hildebrandt G, Kamble RT, Kharfan-Dabaja M, Kindwall-Keller T, Lazarus HM, Marks DI, Nishihori T, Olsson RF, Saad A, Usmani S, Vesole DH, Yared J, Mark T, Nieto Y, Hari P. Allogeneic Transplantation for Relapsed Waldenström Macroglobulinemia and Lymphoplasmacytic Lymphoma. Biol Blood Marrow Transplant. 2017 01;23(1):60-66. PMCID: PMC5182098
41. Cornell RF, D'Souza A, Kassim AA, Costa LJ, Innis-Shelton RD, Zhang MJ, Huang J, Abidi M, Aiello J, Akpek G, Bashey A, Bashir Q, Cerny J, Comenzo R, Diaz MA, Freytes C, Gale RP, Ganguly S, Hamadani M, Hashmi S, Holmberg L, Hossain N, Kamble RT, Kharfan-Dabaja M, Kindwall-Keller T, Kyle R, Kumar S, Lazarus H, Lee C, Maiolino A, Marks DI, Meehan K, Mikhael J, Nath R, Nishihori T, Olsson RF, Ramanathan M, Saad A, Seo S, Usmani S, Vesole D, Vij R, Vogl D, Wirk BM, Yared J, Krishnan A, Mark T, Nieto Y, Hari P. Maintenance versus Induction Therapy Choice on Outcomes after Autologous Transplantation for Multiple Myeloma. Biol Blood Marrow Transplant. 2017 Feb;23(2):269-277. PMCID: PMC5346183
42. Dhakal B, Nelson A, Guru Murthy GS, Fraser R, Eastwood D, Hamadani M, Pasquini M, D'Souza A, Hari P. Autologous Hematopoietic Cell Transplantation in Patients With Multiple Myeloma: Effect of Age. Clin Lymphoma Myeloma Leuk. 2017 03;17(3):165-172.
43. Dhakal B, Fenske TS, Ramalingam S, Shuff J, Epperla N, Hosking P, Rein L, Banerjee A, Hari P, D'Souza A, Shah N, Siker M, Griepentrog GJ, Harris GJ, Wells TS, Erickson BA, Hamadani M. Local Disease Control in Ocular Adnexal Lymphoproliferative Disorders: Comparative Outcomes of MALT Versus Non-MALT Histologies. Clin Lymphoma Myeloma Leuk. 2017 05;17(5):305-311.e2.
44. El-Jawahri A, Chen YB, Brazauskas R, He N, Lee SJ, Knight JM, Majhail N, Buchbinder D, Schears RM, Wirk BM, Wood WA, Ahmed I, Aljurf M, Szer J, Beattie SM, Battiwalla M, Dandoy C, Diaz MA, D'Souza A, Freytes CO, Gajewski J, Gergis U, Hashmi SK, Jakubowski A, Kamble RT, Kindwall-Keller T, Lazarus HM, Malone AK, Marks DI, Meehan K, Savani BN, Olsson RF, Rizzieri D, Steinberg A, Speckhart D, Szwajcer D, Schoemans H, Seo S, Ustun C, Atsuta Y, Dalal J, Sales-Bonfim C, Khera N, Hahn T, Saber W. Impact of pre-transplant depression on outcomes of allogeneic and autologous hematopoietic stem cell transplantation. Cancer. 2017 05 15;123(10):1828-1838. PMCID: PMC5419891
45. Garderet L, D'Souza A, Jacobs P, van Biezen A, Schönland S, Kroeger N, Morris C, Hari P. Response Assessment in Myeloma: Practical Manual on Consistent Reporting in an Era of Dramatic Therapeutic Advances. Biol Blood Marrow Transplant. 2017 Jul;23(7):1193-1202.
46. Kanate AS, Hari PN, Pasquini MC, Visotcky A, Ahn KW, Boyd J, Guru Murthy GS, Rizzo JD, Saber W, Drobyski W, Michaelis L, Atallah E, Carlson KS, D'Souza A, Fenske TS, Cumpston A, Bunner P, Craig M, Horowitz MM, Hamadani M. Recipient Immune Modulation with Atorvastatin for Acute Graft-versus-Host Disease Prophylaxis after Allogeneic Transplantation. Biol Blood Marrow Transplant. 2017 Aug;23(8):1295-1302.
47. Schriber JR, Hari PN, Ahn KW, Fei M, Costa LJ, Kharfan-Dabaja MA, Angel-Diaz M, Gale RP, Ganguly S, Girnius SK, Hashmi S, Pawarode A, Vesole DH, Wiernik PH, Wirk BM, Marks DI, Nishihori T, Olsson RF, Usmani SZ, Mark TM, Nieto YL, D'Souza A. Hispanics have the lowest stem cell transplant utilization rate for autologous hematopoietic cell transplantation for multiple myeloma in the United States: A CIBMTR report. Cancer. 2017 Aug 15;123(16):3141-3149. PMCID: PMC5544566
48. Muffly L, Pasquini MC, Martens M, Brazauskas R, Zhu X, Adekola K, Aljurf M, Ballen KK, Bajel A, Baron F, Battiwalla M, Beitinjaneh A, Cahn JY, Carabasi M, Chen YB, Chhabra S, Ciurea S, Copelan E, D'Souza A, Edwards J, Foran J, Freytes CO, Fung HC, Gale RP, Giralt S, Hashmi SK, Hildebrandt GC, Ho V, Jakubowski A, Lazarus H, Luskin MR, Martino R, Maziarz R, McCarthy P, Nishihori T, Olin R, Olsson RF, Pawarode A, Peres E, Rezvani AR, Rizzieri D, Savani BN, Schouten HC, Sabloff M, Seftel M, Seo S, Sorror ML, Szer J, Wirk BM, Wood WA, Artz A. Increasing use of allogeneic hematopoietic cell transplantation in patients aged 70 years and older in the United States. Blood. 2017 08 31;130(9):1156-1164. PMCID: PMC5580273
49. D'Souza A, Lee S, Zhu X, Pasquini M. Current Use and Trends in Hematopoietic Cell Transplantation in the United States. Biol Blood Marrow Transplant. 2017 Sep;23(9):1417-1421. PMCID: PMC5565685
50. D'Souza A, Zhang MJ, Huang J, Fei M, Pasquini M, Hamadani M, Hari P. Trends in pre- and post-transplant therapies with first autologous hematopoietic cell transplantation among patients with multiple myeloma in the United States, 2004-2014. Leukemia. 2017 09;31(9):1998-2000. PMCID: PMC5587375
51. D'Souza A, Pasquini M, Logan B, Giralt S, Krishnan A, Antin J, Howard A, Goodman S, Qazilbash M, Knust K, Sahebi F, Weisdorf D, Vesole D, Stadtmauer E, Maloney D, Hari P. Heavy/light chain ratio normalization prior to transplant is of independent prognostic significance in multiple myeloma: a BMT CTN 0102 correlative study. Br J Haematol. 2017 09;178(5):816-819. PMCID: PMC5154782
52. Dispenzieri A, D'Souza A, Gertz MA, Laumann K, Wiseman G, Lacy MQ, LaPlant B, Buadi F, Hayman SR, Kumar SK, Dingli D, Hogan WJ, Ansell SM, Gastineau DA, Inwards DJ, Micallef IN, Porrata LF, Johnston PB, Litzow MR, Witzig TE. A phase 1 trial of <sup>90</sup>Y-Zevalin radioimmunotherapy with autologous stem cell transplant for multiple myeloma. Bone Marrow Transplant. 2017 Oct;52(10):1372-1377.
53. Thompson J, Yin Z, D'Souza A, Fenske T, Hamadani M, Hari P, Rizzo JD, Pasquini M, Saber W, Shah N, Shaw BE, Shahir K, Banerjee A, Drobyski WR. Etanercept and Corticosteroid Therapy for the Treatment of Late-Onset Idiopathic Pneumonia Syndrome. Biol Blood Marrow Transplant. 2017 Nov;23(11):1955-1960.
54. D'Souza A, Flynn K, Chhabra S, Dhakal B, Hamadani M, Jacobsen K, Pasquini M, Weihrauch D, Hari P. Rationale and design of DUAL study: Doxycycline to Upgrade response in light chain (AL) amyloidosis (DUAL): A phase 2 pilot study of a two-pronged approach of prolonged doxycycline with plasma cell-directed therapy in the treatment of AL amyloidosis. Contemp Clin Trials Commun. 2017 Dec;8:33-38. PMCID: PMC5898504
55. Mahindra A, Hari P, Fraser R, Fei M, Huang J, Berdeja J, Callander N, Costa L, Diaz MA, Freytes C, Gale RP, Girnius S, Holmberg L, Kharfan-Dabaja M, Kumar S, Kyle R, Lazarus H, Lee C, Maiolino A, Moreb J, Nishihori T, Pawarode A, Saad A, Savani BN, Schriber J, William B, Wirk BM, Krishnan A, Nieto Y, D'Souza A. Autologous hematopoietic cell transplantation for multiple myeloma patients with renal insufficiency: a center for international blood and marrow transplant research analysis. Bone Marrow Transplant. 2017 Dec;52(12):1616-1622. PMCID: PMC5859934
56. Badar T, D'Souza A, Hari P. Recent advances in understanding and treating immunoglobulin light chain amyloidosis. F1000Res. 2018;7. PMCID: PMC6117860
57. D'Souza A, Spellecy R, Derse A. Engender trust and edify. Bone Marrow Transplant. 2018 01;53(1):104.
58. Myers RM, Hill BT, Shaw BE, Kim S, Millard HR, Battiwalla M, Majhail NS, Buchbinder D, Lazarus HM, Savani BN, Flowers MED, D'Souza A, Ehrhardt MJ, Langston A, Yared JA, Hayashi RJ, Daly A, Olsson RF, Inamoto Y, Malone AK, DeFilipp Z, Margossian SP, Warwick AB, Jaglowski S, Beitinjaneh A, Fung H, Kasow KA, Marks DI, Reynolds J, Stockerl-Goldstein K, Wirk B, Wood WA, Hamadani M, Satwani P. Long-term outcomes among 2-year survivors of autologous hematopoietic cell transplantation for Hodgkin and diffuse large b-cell lymphoma. Cancer. 2018 02 15;124(4):816-825. PMCID: PMC5871233
59. Dhakal B, Szabo A, Chhabra S, Hamadani M, D'Souza A, Usmani SZ, Sieracki R, Gyawali B, Jackson JL, Asimakopoulos F, Hari PN. Autologous Transplantation for Newly Diagnosed Multiple Myeloma in the Era of Novel Agent Induction: A Systematic Review and Meta-analysis. JAMA Oncol. 2018 Mar 01;4(3):343-350. PMCID: PMC5885822
60. Htut M, D'Souza A, Krishnan A, Bruno B, Zhang MJ, Fei M, Diaz MA, Copelan E, Ganguly S, Hamadani M, Kharfan-Dabaja M, Lazarus H, Lee C, Meehan K, Nishihori T, Saad A, Seo S, Ramanathan M, Usmani SZ, Gasparetto C, Mark TM, Nieto Y, Hari P. Autologous/Allogeneic Hematopoietic Cell Transplantation versus Tandem Autologous Transplantation for Multiple Myeloma: Comparison of Long-Term Postrelapse Survival. Biol Blood Marrow Transplant. 2018 03;24(3):478-485. PMCID: PMC5826888
61. Kumar SK, Dispenzieri A, Fraser R, Mingwei F, Akpek G, Cornell R, Kharfan-Dabaja M, Freytes C, Hashmi S, Hildebrandt G, Holmberg L, Kyle R, Lazarus H, Lee C, Mikhael J, Nishihori T, Tay J, Usmani S, Vesole D, Vij R, Wirk B, Krishnan A, Gasparetto C, Mark T, Nieto Y, Hari P, D'Souza A. Early relapse after autologous hematopoietic cell transplantation remains a poor prognostic factor in multiple myeloma but outcomes have improved over time. Leukemia. 2018 04;32(4):986-995. PMCID: PMC5871538
62. Drobyski WR, Szabo A, Zhu F, Keever-Taylor C, Hebert KM, Dunn R, Yim S, Johnson B, D'Souza A, Eapen M, Fenske TS, Hari P, Hamadani M, Horowitz MM, Rizzo JD, Saber W, Shah N, Shaw B, Pasquini M. Tocilizumab, tacrolimus and methotrexate for the prevention of acute graft-<i>versus</i>-host disease: low incidence of lower gastrointestinal tract disease. Haematologica. 2018 04;103(4):717-727. PMCID: PMC5865423
63. Shah NN, Ahn KW, Litovich C, Fenske TS, Ahmed S, Battiwalla M, Bejanyan N, Dahi PB, Bolaños-Meade J, Chen AI, Ciurea SO, Bachanova V, DeFilipp Z, Epperla N, Farhadfar N, Herrera AF, Haverkos BM, Holmberg L, Hossain NM, Kharfan-Dabaja MA, Kenkre VP, Lazarus HM, Murthy HS, Nishihori T, Rezvani AR, D'Souza A, Savani BN, Ulrickson ML, Waller EK, Sureda A, Smith SM, Hamadani M. Outcomes of Medicare-age eligible NHL patients receiving RIC allogeneic transplantation: a CIBMTR analysis. Blood Adv. 2018 04 24;2(8):933-940. PMCID: PMC5916010
64. Knight JM, Kerswill SA, Hari P, Cole SW, Logan BR, D'Souza A, Shah NN, Horowitz MM, Stolley MR, Sloan EK, Giles KE, Costanzo ES, Hamadani M, Chhabra S, Dhakal B, Rizzo JD. Repurposing existing medications as cancer therapy: design and feasibility of a randomized pilot investigating propranolol administration in patients receiving hematopoietic cell transplantation. BMC Cancer. 2018 May 24;18(1):593. PMCID: PMC5968588
65. Hammons L, Brazauskas R, Pasquini M, Hamadani M, Hari P, D'Souza A. Presence of fluorescent in situ hybridization abnormalities is associated with plasma cell burden in light chain amyloidosis. Hematol Oncol Stem Cell Ther. 2018 Jun;11(2):105-111.
66. Wright NL, Flynn KE, Brazauskas R, Hari P, D'Souza A. Patient-reported distress is prevalent in systemic light chain (AL) amyloidosis but not determined by severity of disease. Amyloid. 2018 Jun;25(2):129-134.
67. Dhakal B, D'Souza A, Lakshman A, Hamadani M, Chhabra S, Thompson R, Shah N, Pasquini M, Hari P. Pharmacokinetics of High-Dose Propylene Glycol-Free Melphalan in Multiple Myeloma Patients Undergoing Autologous Hematopoietic Cell Transplantation. Biol Blood Marrow Transplant. 2018 08;24(8):1610-1614.
68. Raj RV, Hamadani M, Szabo A, Pasquini MC, Shah NN, Drobyski WR, Shaw BE, Saber W, Rizzo JD, Jerkins J, Fenske TS, D'Souza A, Dhakal B, Zhang C, Konings S, Hari PN, Chhabra S. Peripheral Blood Grafts for T Cell-Replete Haploidentical Transplantation Increase the Incidence and Severity of Cytokine Release Syndrome. Biol Blood Marrow Transplant. 2018 08;24(8):1664-1670.
69. D'Souza A, Millard H, Knight J, Brazauskas R, Lee SJ, Flynn KE, Rizzo JD, Shaw BE. Prevalence of self-reported sleep dysfunction before allogeneic hematopoietic cell transplantation. Bone Marrow Transplant. 2018 08;53(8):1079-1082. PMCID: PMC6098949
70. Badar T, Hari P, Chhabra S, Dhakal B, Drobyski WR, Fenske TS, Hamadani M, Pasquini M, Saber W, Shah NN, Shaw BE, D'Souza A. Use of propylene glycol-free melphalan conditioning in light-chain amyloidosis patients undergoing autologous hematopoietic cell transplantation is well tolerated and effective. Bone Marrow Transplant. 2018 09;53(9):1210-1213.
71. Quock TP, Chang E, Munday JS, D'Souza A, Gokhale S, Yan T. Mortality and healthcare costs in Medicare beneficiaries with AL amyloidosis. J Comp Eff Res. 2018 11;7(11):1053-1062.
72. Radivoyevitch T, Dean RM, Shaw BE, Brazauskas R, Tecca HR, Molenaar RJ, Battiwalla M, Savani BN, Flowers MED, Cooke KR, Hamilton BK, Kalaycio M, Maciejewski JP, Ahmed I, Akpek G, Bajel A, Buchbinder D, Cahn JY, D'Souza A, Daly A, DeFilipp Z, Ganguly S, Hamadani M, Hayashi RJ, Hematti P, Inamoto Y, Khera N, Kindwall-Keller T, Landau H, Lazarus H, Majhail NS, Marks DI, Olsson RF, Seo S, Steinberg A, William BM, Wirk B, Yared JA, Aljurf M, Abidi MH, Allewelt H, Beitinjaneh A, Cook R, Cornell RF, Fay JW, Hale G, Chakrabarty JH, Jodele S, Kasow KA, Mahindra A, Malone AK, Popat U, Rizzo JD, Schouten HC, Warwick AB, Wood WA, Sekeres MA, Litzow MR, Gale RP, Hashmi SK. Risk of acute myeloid leukemia and myelodysplastic syndrome after autotransplants for lymphomas and plasma cell myeloma. Leuk Res. 2018 11;74:130-136. PMCID: PMC6219911
73. Scott EC, Hari P, Kumar S, Fraser R, Davila O, Shah N, Gale RP, Diaz MA, Agrawal V, Cornell RF, Ganguly S, Akpek G, Freytes C, Hashmi S, Malek E, Kamble RT, Lazarus H, Solh M, Usmani SZ, Kanate AS, Saad A, Chhabra S, Gergis U, Cerny J, Kyle RA, Lee C, Kindwall-Keller T, Assal A, Hildebrandt GC, Holmberg L, Maziarz RT, Nishihori T, Seo S, Kumar S, Mark T, D'Souza A. Staging Systems for Newly Diagnosed Myeloma Patients Undergoing Autologous Hematopoietic Cell Transplantation: The Revised International Staging System Shows the Most Differentiation between Groups. Biol Blood Marrow Transplant. 2018 12;24(12):2443-2449. PMCID: PMC6293469
74. Guru Murthy GS, Hari PN, Szabo A, Pasquini M, Narra R, Khan M, Abedin S, Chhabra S, Dhakal B, D'Souza A, Drobyski WR, Rizzo JD, Runaas L, Shah NN, Shaw B, Saber W, Fenske T, Hamadani M. Outcomes of Reduced-Intensity Conditioning Allogeneic Hematopoietic Cell Transplantation Performed in the Inpatient versus Outpatient Setting. Biol Blood Marrow Transplant. 2019 04;25(4):827-833.
75. Gopalakrishnan S, D'Souza A, Scott E, Fraser R, Davila O, Shah N, Gale RP, Kamble R, Diaz MA, Lazarus HM, Savani BN, Hildebrandt GC, Solh M, Freytes CO, Lee C, Kyle RA, Usmani SZ, Ganguly S, Assal A, Berdeja J, Kanate AS, Dhakal B, Meehan K, Kindwall-Keller T, Saad A, Locke F, Seo S, Nishihori T, Gergis U, Gasparetto C, Mark T, Nieto Y, Kumar S, Hari P. Revised International Staging System Is Predictive and Prognostic for Early Relapse (&lt;24 months) after Autologous Transplantation for Newly Diagnosed Multiple Myeloma. Biol Blood Marrow Transplant. 2019 04;25(4):683-688. PMCID: PMC6453717
76. Voshtina E, Szabo A, Hamadani M, Fenske TS, D'Souza A, Chhabra S, Saber W, Drobyski WR, Hari P, Shah NN. Impact of Obesity on Clinical Outcomes of Elderly Patients Undergoing Allogeneic Hematopoietic Cell Transplantation for Myeloid Malignancies. Biol Blood Marrow Transplant. 2019 01;25(1):e33-e38.
77. Sahebi F, Garderet L, Kanate AS, Eikema DJ, Knelange NS, Alvelo OFD, Koc Y, Blaise D, Bashir Q, Moraleda JM, Dreger P, Sanchez JF, Ciurea S, Schouten H, Shah NN, Verbeek M, Rösler W, Diez-Martin JL, Schoenland S, D'Souza A, Kröger N, Hari P. Outcomes of Haploidentical Transplantation in Patients with Relapsed Multiple Myeloma: An EBMT/CIBMTR Report. Biol Blood Marrow Transplant. 2019 02;25(2):335-342. PMCID: PMC6339830
78. Kilari D, D'Souza A, Fraser R, Qayed M, Davila O, Agrawal V, Diaz MA, Chhabra S, Cerny J, Copelan E, Farhadfar N, Freytes CO, Gale RP, Ganguly S, Hildebrandt GC, Holmberg L, Kamble RT, Kapoor P, Lazarus H, Lee C, Murthy HS, Naik S, Nishihori T, Saad A, Savani BN, Seo S, Warwick A, Wirk B, Yared JA, Nieto Y, Hari P. Autologous Hematopoietic Stem Cell Transplantation for Male Germ Cell Tumors: Improved Outcomes Over 3 Decades. Biol Blood Marrow Transplant. 2019 06;25(6):1099-1106. PMCID: PMC6559839
79. Patel G, Hari P, Szabo A, Rein L, Kreuziger LB, Chhabra S, Dhakal B, D'Souza A. Acquired factor X deficiency in light-chain (AL) amyloidosis is rare and associated with advanced disease. Hematol Oncol Stem Cell Ther. 2019 Mar;12(1):10-14.
80. D'Souza A, Hari P, Pasquini M, Braun T, Johnson B, Lundy S, Couriel D, Hamadani M, Magenau J, Dhakal B, Shah NN, Riwes M, Parkin B, Reddy P, Pawarode A. A Phase 2 Study of Pembrolizumab during Lymphodepletion after Autologous Hematopoietic Cell Transplantation for Multiple Myeloma. Biol Blood Marrow Transplant. 2019 08;25(8):1492-1497.
81. Flynn KE, Myers JM, D'Souza A, Schiffer CA, Thompson JE, Atallah E. Exploring Patient Decision Making Regarding Discontinuation of Tyrosine Kinase Inhibitors for Chronic Myeloid Leukemia. Oncologist. 2019 09;24(9):1253-1258. PMCID: PMC6738285
82. Shaw BE, D'Souza A, Lee SJ. Importance of Assessing Patient-Reported Outcomes With Salvage Autologous Transplantation in Relapsed Multiple Myeloma. J Clin Oncol. 2019 07 01;37(19):1598-1600. PMCID: PMC6879316
83. Dhakal B, Giri S, Levin A, Rein L, Fenske TS, Chhabra S, Shah NN, Szabo A, D'Souza A, Pasquini M, Hari P, Hamadani M. Factors Associated With Unplanned 30-Day Readmissions After Hematopoietic Cell Transplantation Among US Hospitals. JAMA Netw Open. 2019 07 03;2(7):e196476.
84. Quock TP, Yan T, Tieu R, D'Souza A, Broder MS. Untangling the clinical and economic burden of hospitalization for cardiac amyloidosis in the United States. Clinicoecon Outcomes Res. 2019;11:431-439. PMCID: PMC6643051
85. Dhakal B, D'Souza A, Hamadani M, Arce-Lara C, Schroeder K, Chhabra S, Shah NN, Gauger K, Keaton T, Pasquini M, Hari P. Phase I/II trial of bendamustine, ixazomib, and dexamethasone in relapsed/refractory multiple myeloma. Blood Cancer J. 2019 07 29;9(8):56. PMCID: PMC6663939
86. Badar T, Khan MA, Szabo A, Drobyski W, Chhabra S, Dhakal B, Fenske TS, Hamadani M, Hari P, Jerkins JH, Shah NN, Shaw BE, D'Souza A. Incidence and characteristics of engraftment syndrome after autologous hematopoietic cell transplantation in light chain amyloidosis. Amyloid. 2019 Dec;26(4):210-215.
87. D'Souza A, Hari P, Pasquini M, Jacobsen K, Flynn KE. Baseline patient-reported outcomes in light-chain amyloidosis patients enrolled on an interventional clinical trial. Amyloid. 2019;26(sup1):87-88. PMCID: PMC7108667
88. Badar T, Dhakal B, Szabo A, Padmanabhan A, Johnson BD, Heidtke S, Esselmann J, Chhabra S, Hamadani M, Hari P, D'Souza A. An updated single center experience with plerixafor and granulocyte colony-stimulating factor for stem cell mobilization in light chain amyloidosis. J Clin Apher. 2019 Dec;34(6):686-691. PMCID: PMC6957224
89. Warsame R, D'Souza A. Patient Reported Outcomes Have Arrived: A Practical Overview for Clinicians in Using Patient Reported Outcomes in Oncology. Mayo Clin Proc. 2019 11;94(11):2291-2301. PMCID: PMC6832764
90. Buchbinder D, Brazauskas R, Bo-Subait K, Ballen K, Parsons S, John T, Hahn T, Sharma A, Steinberg A, D'Souza A, Kumar AJ, Yoshimi A, Wirk B, Shaw B, Freytes C, LeMaistre C, Bredeson C, Dandoy C, Almaguer D, Marks DI, Szwajcer D, Hale G, Schouten H, Hashem H, Schoemans H, Murthy HS, Lazarus HM, Cerny J, Tay J, Yared JA, Adekola K, Schultz KR, Lehmann L, Burns L, Aljurf M, Diaz MA, Majhail N, Farhadfar N, Kamble R, Olsson R, Schears R, Seo S, Beattie S, Chhabra S, Savani BN, Badawy S, Ganguly S, Ciurea S, Marino S, Gergis U, Kuwatsuka Y, Inamoto Y, Khera N, Hashmi S, Wood W, Saber W. Predictors of Loss to Follow-Up Among Pediatric and Adult Hematopoietic Cell Transplantation Survivors: A Report from the Center for International Blood and Marrow Transplant Research. Biol Blood Marrow Transplant. 2020 Mar;26(3):553-561. PMCID: PMC7367505
91. Flynn KE, Vanness DJ, Myers JM, D'Souza A, Schiffer CA, Thompson JE, Atallah E. In Reply. Oncologist. 2020 04;25(4):e744-e745. PMCID: PMC7160403
92. Dunavin N, Mau LW, Meyer CL, Divine C, Abdallah AO, Leppke S, D'Souza A, Denzen E, Saber W, Burns LJ, Ganguly S. Health Care Reimbursement, Service Utilization, and Outcomes among Medicare Beneficiaries with Multiple Myeloma Receiving Autologous Hematopoietic Cell Transplantation in Inpatient and Outpatient Settings. Biol Blood Marrow Transplant. 2020 Apr;26(4):805-813.
93. Bhasin B, Szabo A, Wu R, Saad ER, Hari P, Dhakal B, Chhabra S, D'Souza A. Monoclonal Gammopathies After Renal Transplantation: A Single-center Study. Clin Lymphoma Myeloma Leuk. 2020 Aug;20(8):e468-e473. PMCID: PMC7450520
94. Dhakal B, Patel S, Girnius S, Bachegowda L, Fraser R, Davila O, Kanate AS, Assal A, Hanbali A, Bashey A, Pawarode A, Freytes CO, Lee C, Vesole D, Cornell RF, Hildebrandt GC, Murthy HS, Lazarus HM, Cerny J, Yared JA, Schriber J, Berdeja J, Stockerl-Goldstein K, Meehan K, Holmberg L, Solh M, Diaz MA, Kharfan-Dabaja MA, Farhadfar N, Bashir Q, Munker R, Olsson RF, Gale RP, Bayer RL, Seo S, Chhabra S, Hashmi S, Badawy SM, Nishihori T, Gonsalves W, Nieto Y, Efebera Y, Kumar S, Shah N, Qazilbash M, Hari P, D'Souza A. Hematopoietic cell transplantation utilization and outcomes for primary plasma cell leukemia in the current era. Leukemia. 2020 Apr 20. PMCID: PMC7572530
95. Hamadani M, Zhang MJ, Tang XY, Fei M, Brunstein C, Chhabra S, D'Souza A, Milano F, Phelan R, Saber W, Shaw BE, Weisdorf D, Devine SM, Horowitz MM. Graft Cryopreservation Does Not Impact Overall Survival after Allogeneic Hematopoietic Cell Transplantation Using Post-Transplantation Cyclophosphamide for Graft-versus-Host Disease Prophylaxis. Biol Blood Marrow Transplant. 2020 07;26(7):1312-1317. PMCID: PMC7194895
96. Dhakal B, Narra RK, Giri S, Szabo A, Smunt TL, Ghose S, Pathak LK, Aryal M, Hamadani M, Chhabra S, Janz S, D'Souza A, Hari PN. Association of adverse events and associated cost with efficacy for approved relapsed and/or refractory multiple myeloma regimens: A Bayesian network meta-analysis of phase 3 randomized controlled trials. Cancer. 2020 Jun 15;126(12):2791-2801.
97. Cusatis RN, Tecca HR, D'Souza A, Shaw BE, Flynn KE. Prevalence of decisional regret among patients who underwent allogeneic hematopoietic stem cell transplantation and associations with quality of life and clinical outcomes. Cancer. 2020 Jun 01;126(11):2679-2686. PMCID: PMC7220834
98. Knight JM, Rizzo JD, Hari P, Pasquini MC, Giles KE, D'Souza A, Logan BR, Hamadani M, Chhabra S, Dhakal B, Shah N, Sriram D, Horowitz MM, Cole SW. Propranolol inhibits molecular risk markers in HCT recipients: a phase 2 randomized controlled biomarker trial. Blood Adv. 2020 02 11;4(3):467-476. PMCID: PMC7013267
99. Chhabra S, Narra RK, Wu R, Szabo A, George G, Michaelis LC, D'Souza A, Dhakal B, Drobyski WR, Fenske TS, Jerkins JH, Pasquini MC, Rizzo RD, Saber W, Shah NN, Shaw BE, Hamadani M, Hari PN. Fludarabine/Busulfan Conditioning-Based Allogeneic Hematopoietic Cell Transplantation for Myelofibrosis: Role of Ruxolitinib in Improving Survival Outcomes. Biol Blood Marrow Transplant. 2020 May;26(5):893-901.
100. D'Souza A, Magnus BE, Myers J, Dispenzieri A, Flynn KE. The use of PROMIS patient-reported outcomes (PROs) to inform light chain (AL) amyloid disease severity at diagnosis. Amyloid. 2020 Jun;27(2):111-118. PMCID: PMC7275879
101. D'Souza A, Fretham C, Lee SJ, Arora M, Brunner J, Chhabra S, Devine S, Eapen M, Hamadani M, Hari P, Pasquini MC, Perez W, Phelan RA, Riches ML, Rizzo JD, Saber W, Shaw BE, Spellman SR, Steinert P, Weisdorf DJ, Horowitz MM. Current Use of and Trends in Hematopoietic Cell Transplantation in the United States. Biol Blood Marrow Transplant. 2020 Aug;26(8):e177-e182. PMCID: PMC7404814
102. Eapen M, Zhang MJ, Tang XY, Lee SJ, Fei MW, Wang HL, Hebert KM, Arora M, Chhabra S, Devine SM, Hamadani M, D'Souza A, Pasquini MC, Phelan R, Rizzo JD, Saber W, Shaw BE, Weisdorf DJ, Horowitz MM. Hematopoietic Cell Transplantation with Cryopreserved Grafts for Severe Aplastic Anemia. Biol Blood Marrow Transplant. 2020 07;26(7):e161-e166. PMCID: PMC7206419
103. Dhakal B, D'Souza A, Chhabra S, Hari P. Multiple myeloma and COVID-19. Leukemia. 2020 07;34(7):1961-1963.
104. Dhakal B, Miller S, Rein L, Pathak LK, Gloria L, Szabo A, Giri S, Chhabra S, Hamadani M, Paner A, Padmanabhan A, Janz S, D'Souza A, Hari P. Trends in the use of therapeutic plasma exchange in multiple myeloma. J Clin Apher. 2020 Aug;35(4):307-315.
105. D'Souza A, Szabo A, Flynn KE, Dhakal B, Chhabra S, Pasquini MC, Weihrauch D, Hari PN. Adjuvant doxycycline to enhance anti-amyloid effects: Results from the dual phase 2 trial. EClinicalMedicine. 2020 Jun;23:100361. PMCID: PMC7280748
106. Chhabra S, Visotcky A, Pasquini MC, Zhu F, Tang X, Zhang MJ, Thompson R, Abedin S, D'Souza A, Dhakal B, Drobyski WR, Fenske TS, Jerkins JH, Douglas Rizzo J, Runaas L, Saber W, Shah NN, Shaw BE, Horowitz MM, Hari PN, Hamadani M. Ixazomib for Chronic Graft-versus-Host Disease Prophylaxis following Allogeneic Hematopoietic Cell Transplantation. Biol Blood Marrow Transplant. 2020 Oct;26(10):1876-1885. PMCID: PMC7571859
107. Dhakal B, D'Souza A, Kleman A, Chhabra S, Mohan M, Hari P. Salvage second transplantation in relapsed multiple myeloma. Leukemia. 2020 Aug 04.
108. Kanabar D, Farrales P, Kabir A, Juang D, Gnanmony M, Almasri J, Torrents N, Shukla S, Gupta V, Dukhande VV, D'Souza A, Muth A. Optimizing the aryl-triazole of cjoc42 for enhanced gankyrin binding and anti-cancer activity. Bioorg Med Chem Lett. 2020 Sep 01;30(17):127372.
109. Williams A, Baruah D, Patel J, Szabo A, Chhabra S, Dhakal B, Hari P, Janz S, Stolley M, D'Souza A. Prevalence and significance of sarcopenia in multiple myeloma patients undergoing autologous hematopoietic cell transplantation. Bone Marrow Transplant. 2020 Jul 30.
110. Oaknin A, Friedman CF, Roman LD, D'Souza A, Brana I, Bidard FC, Goldman J, Alvarez EA, Boni V, ElNaggar AC, Passalacqua R, Do KTM, Santin AD, Keyvanjah K, Xu F, Eli LD, Lalani AS, Bryce RP, Hyman DM, Meric-Bernstam F, Solit DB, Monk BJ. Neratinib in patients with HER2-mutant, metastatic cervical cancer: Findings from the phase 2 SUMMIT basket trial. Gynecol Oncol. 2020 Oct;159(1):150-156.
111. Chhabra S, Thapa B, Szabo A, Konings S, D'Souza A, Dhakal B, Jerkins JH, Pasquini MC, Johnson BD, Hari PN, Hamadani M. Utilization and Cost Implications of Hematopoietic Progenitor Cells Stored for a Future Salvage Autologous Transplantation or Stem Cell Boost in Myeloma Patients. Biol Blood Marrow Transplant. 2020 Jul 24.
112. Hagen P, D'Souza A, Hari P, Davila O, Zhang MJ, Vesole DH, Smith SE, Rodriguez TE, Stiff PJ. Busulfan, melphalan, and bortezomib compared to melphalan as a high dose regimen for autologous hematopoietic stem cell transplantation in multiple myeloma: long term follow up of a novel high dose regimen. Leuk Lymphoma. 2020 Aug 31:1-9.
113. Mehta A, Fillmore N, Dahiya S, D'Souza A, Sweetenham J, Kansagra A. Reporting of race and ethnicity at an international haematology conference. Br J Haematol. 2020 Aug 30.
114. Cheng Y, Sun F, D'Souza A, Dhakal B, Pisano M, Chhabra S, Stolley M, Hari P, Janz S. Autonomic nervous system control of multiple myeloma. Blood Rev. 2020 Aug 11:100741.
115. Monahan K, Kleman A, Thapa B, Szabo A, D'Souza A, Dhakal B, Jerkins JH, Pasquini MC, Hamadani M, Hari PN, Chhabra S. Propylene Glycol-Free Melphalan versus PG-Melphalan as Conditioning for Autologous Hematopoietic Cell Transplantation for Myeloma. Biol Blood Marrow Transplant. 2020 Sep 11.
 
Books, Chapters, and Reviews
1. D'Souza A, Pasquini M, Wang Z, Rizzo D. Current Trends and Indications for Hematopoietic Cell Transplantation. In: Lazarus HM,Gale RP, Keating A, Bacigalupo A, Munker R, Atkinson K, Abutalib S. (editors) Current Concepts and Controversies in Hematopoietic Cell Transplantation, Cambridge University Press, Cambridge, UK, 2014.
2. Hussain AS and D’Souza A. Light Chain Amyloidosis. In: Zimmerman TM, Kumar SK (editors) Biology and Management of Unusual Plasma Cell Dyscrasias, Springer, 2016.
3. Hussain AS and D’Souza A. Light chain amyloidosis. In: Clinical Manual of Blood and Bone Marrow Transplantation, Wiley, 2017.
4. D'Souza A, Gertz MA. Waldenström's Macroglobulinemia Cancer Consult: Expertise for Clinical Practice. June 20, 2014:371-375.
 
Abstracts
1. Clupper, DC, D'Souza A, Jaroch DB, Modulation of Ciprofloxacin Release from Sol-Gel derived Silica Matrices, Poster Presentation at the 32nd Annual Meeting of the Society for Biomaterials, Chicago, IL, 2007
2. D'Souza A, Muckey B, Azrak F, Hydralazine- Induced Pulmonary- Renal Syndrome, Oral Presentation at American College of Physicians(ACP) Associates Meeting, Michigan Chapter, Sterling Heights, MI, 05/2008 (First place, Oral presentation-Case report)
3. D'Souza A, Muckey B, Azrak F, Hydralazine- Induced Pulmonary- Renal Syndrome, Oral Presentation at Michigan American College of Physicians(ACP) Regional conference, Detroit, MI, 09/2008 (Third place, Oral presentation-Case report).
4. D'Souza A, Mukherjee S, Barnes M, Eosinophilia-An Unusual Manifestation of a Common Disease or a Mere Confounding Association? Poster Presentation at American College of Physicians(ACP) National Meeting, Washington D.C., 05/2008
5. D'Souza A, Moukabary T, Shoichet S, Fatal Sickling Crisis Triggered by Previously Undiagnosed Lupus. Poster Presentation at American College of Physicians(ACP) National Meeting, Washington D.C., 05/2008
6. D'Souza A, Agrawal V, Barnes MA, A Dermatological Surprise Associated with Subclinical Chronic Lymphocytic Leukemia, Poster Presentation at American College of Physicians(ACP) Michigan Chapter, Traverse City, MI, 09/2008
7. D'Souza A, All that wheezes is not Asthma, Poster Presentation at American College of Physicians (ACP) Michigan Chapter, Sterling Heights, MI, 09/2009
8. Pieper M, D'Souza A, Wolanskyj A, An Atypical Normocytic Anemia- Mind the Medication List, Poster Presentation at American College of Physicians(ACP) Minnesota Chapter, Minneapolis, MN, 11/2010
9. D'Souza A, Doherty L, Ducaine W, Zakalik D. Impact of BRCA1/BRCA2 gene mutation testing on surgical decision-making in newly diagnosed breast cancer patients. Cancer Res. 2010;70(24 Suppl):P2-10-03.
10. D'Souza A, Hayman S, Buadi F, Gertz M, Lacy M, Mauermann M, Greipp P, Zeldenrust S, Kumar S, Kyle R, Lust J, Detweiler K, Dingli D, Russell S, Witzig T, Rajkumar SV, Dispenzieri A. Baseline plasma VEGF levels in POEMS and related disorders. Haematologica 2011;96S:S154
11. D'Souza A, Hayman S, Buadi F, Gertz M, Lacy M, Mauerman M, Greipp P, Zeldenrust S, Kumar S, Kyle R, Lust J, Detweiler K, Dingli D, Russell S, Witzig T, Rajkumar SV, Dispenzieri A. Utility of plasma VEGF levels in the follow-up of patients with POEMS. Haematologica 2011;96S:S157.
12. D'Souza A, Outcomes after autologous stem cell transplantation for POEMS syndrome (osteosclerotic myeloma): A single center experience, Oral Presentation at the First Annual Mentoring Program for Stem Cell Transplantation Fellows, Atlanta, GA, 01/2012
13. D'Souza A, Theis J, Quint P, Vrana J, Gertz M, Kyle R, Zelderust S, Dogan A, Dispenzieri A. Amyloidosis of lymph nodes: a proteomic analysis using tandem mass spectrometry. Amyloid 2013.
14. Jaben E, Tauscher C, D'Souza A, Hogan W, Stubbs J, Eapen J Clinically significant anti-A1 (ABO) in a presumed ABO-identical hematopoietic stem cell (HSC) transplant recipient. Transfusion 2011;51s:220A
15. D'Souza A, Armasu S, De Andrade M, Heit J Replication of Candidate Gene Single Nucleotide Polymorphisms (SNPs) Previously Reported As Associated with Venous Thromboembolism. Blood 2011;118:123.
16. D'Souza A, Buadi F, Lacy M, Gertz M, Hayman S, Kumar S, Dingli D, Zeldenrust S, Dispenzieri A Relapse of POEMS Syndrome following autologous stem cell transplantation: a single center experience. Blood 2011;118:3101.
17. D'Souza A, Buadi F, Lacy M, Gertz M, Hayman S, Kumar S, Dingli D, Zeldenrust S, Kyle R, Dispenzieri A, Outcomes after autologous stem cell transplantation for POEMS syndrome (osteosclerotic myeloma): A single center experience, Poster Presentation at the 22nd Annual Mayo Clinic Hematology/Oncology Reviews, 2012. Received a Fellow Travel Award.
18. O'Reilly A, D'Souza A, Price D Localized amyloidosis of the tongue: A review of the Mayo Clinic experience. Otolaryngol Head Neck Surg 2012;147:P165.
19. Mereuta O, D'Souza A, Vrana J, Theis J, Quint P, Dispenzieri A, Grogg K, Dogan A. Localized Amyloidosis of the Urinary Bladder: New Pathological Features Revealed by Mass Spectrometry-Based Proteomics. Modern Pathology. Mod Pathol. 2013;26:234A
20. Mereuta O, D'Souza A, Vrana J, Theis J, Quint P, Dispenzieri A, Grogg K, Dogan A Amyloidosis of the Urinary Bladder: New Pathological Features Revealed by Mass Spectrometry-Based Proteomics. Mod Pathol. 2013;26:234A. Lab Invest. 2013;93:234A.
21. D'Souza A, Theis J, Vrana J, Dogan A. Drug-induced amyloidosis: a proteomic insight into 52 cases. Blood 2013;122:1871.
22. Karam C, Klein C, Dispenzieri A, Mandrekar J, Dyck J, D'Souza A, Mauermann M. Neuropathy Improvement following Peripheral Blood Stem Cell Transplantation for POEMS Syndrome. Neurology 2014 82(10):Supplement I6-2.002
23. D'Souza A, Wirk B, Zhang, MJ, Huang J, Krishnan A, Mark T, Gasparetto C, Hari PN. Improved Outcomes of Autologous Hematopoietic Cell Transplantation for Light Chain Amyloidosis: A Center for International Blood and Marrow Transplant Registry (CIBMTR) Study. Blood 2014;124:193
24. Costa LJ, Uy G, Hari PN, Zhang MJ, Huang J, Krishnan A, Mark TM, D'Souza A. Contribution of Chemotherapy Mobilization to Disease Control in Multiple Myeloma Treated with Autologous Transplantation. Blood 2014;124:2447.
25. Dhakal B, Brazauskas R, Arce-Lara C, Hari PN, Pasquini MC, D'Souza A. Monocyte Recovery at Day 100 is Associated with Improved Survival in Multiple Myeloma Patients Who Undergo Allogeneic Hematopoietic Cell Transplantation. Biol Blood Marrow Transpl 2015; 21(2):S163-S164.
26. Dhakal B, Martens M, Kapke J, D'Souza A, Pasquini M, Saber W, Hamadani M, Drobyski W, Horowitz M, Zhang M-J, Hari P. Outcomes of Allogeneic Hematopoietic Cell Transplantation for Multiple Myeloma: Impact of Disease Risk and Conditioning Regimen. Biol Blood Marrow Transpl 2015; 21(2):S278-S279.
27. Hari P, Cornell RF, Zhang MJ, Huang J, Kassim A, Costa L, Innis-Shelton RD, Mark T, Nieto YL, Gasparetto C, Krishnan A, D'Souza A. Induction regimens for autologous transplant eligible myeloma patients- Doublets or Triplets and Which Triplet? Clinical Lymphoma, Myeloma and Leukemia, 2015; 15: e51.
28. D'Souza A, Huang J, Hari P. Validation of the 2012 hematologic response criteria in light chain amyloidosis using the Center for International Blood and Marrow Transplant (CIBMTR) database. Clinical Lymphoma Myeloma and Leukemia, 2015; 15: e182-e183
29. Hari P, Cornell RF, Zhang MJ, Huang J, Kassim A, Costa L, Innis-Shelton RD, Mark T, Nieto YL, Gasparetto C, Krishnan A, D'Souza A. Induction regimens for autologous transplant eligible myeloma patients- Doublets or Triplets and Which Triplet? Poster with Discussion at the 15th International Myeloma Workshop, Clinical Lymphoma, Myeloma and Leukemia 2015; 15: e51.
30. D'Souza A, Pasquini M, Logan B, Giralt S, Krishnan A, Antin JH, Howard A, Horowitz M, Goodman S, Laport G, Qazilbash MH, Mendizabal MS, Sahebi F, Weisdorf D, Vesole D, Stadtmauer E, Maloney D, Hari P, Heavy Light Chain Ratio Normalization Allows Identification of Electrophoretic Non-Complete Response Patients with Improved Outcomes: A Long Term Follow Up Update for BMT CTN 0102 Correlative Study. Poster Presentation at the 20th Annual European Hematology Association Meeting, Haematologica 2015;S1:P664.
31. Dhakal B, Ramalingam S, Shuff J, Epperla N, Rein L, Banerjee A, Siker M, Hosking PR, Hari P, D'Souza A, Atallah E, Erickson B, Fenske TS, Hamadani M. Local Control of Ocular Adnexal Lymphoproliferative Disorders (OALD): Similar Outcomes in MALT and Non-MALT Histologies. Poster Presentation at 57th Annual Meeting of the American Society of Hematology, Blood 2015;126:2711
32. Cornell RF, Costa LJ, Kassim AA, Inns-Shelton R, Krishnan A, Mark T, Nieto Y, Gasparetto CJ, D'Souza A, Hari P, Zhang MJ, Huang J. Post-Transplant Therapy is More Important Than Induction Regimen Chocie in Autologous Hematopoietic Cell Transplantation (AHCT) Recipients for Multiple Myeloma (MM). Oral Presentation at 57th Annual Meeting of the American Society of Hematology, Blood 2015;126:396
33. Sharma M, Hari P, Le-Rademacher J, Krishnan A, Nieto Y, Gasparetto C, Huang J, Scott EC, D'Souza A. Autologous Hematopoietic Cell Transplantation in Patients with High Risk Multiple Myeloma: Post-Transplant Responses Do Not Translate to Longer Survival. Poster Presentation at 57th Annual Meeting of the American Society of Hematology, Blood 2015; 126: 1979
34. Hamadani M, Pasquini M, Visotcky A, Ahn KW, Horowitz MM, Boyd J, Rizzo JD, Saber W, Drobyski W, Arce-Lara C, D'Souza A, Fenske TS, Cumpston A, Bunner P, Craig M, Hari PN, Kanate AS. Prospective, Multicenter Clinical Trial of Atorvastatin-Based Acute Graft-Versus-Host-Disease (aGVHD) Prophylaxis in Recipients of HLA-Matched Related Donor (MRD) and Matched Unrelated Donor (MUD) Allogeneic Hematopoietic Cell Transplantation (alloHCT). Oral presentation at Annual BMT Tandem Meetings 2016, Biol Blood Marrow Transpl 2016;22(3):S47-S48.
35. Muffly L, Pasquini M, Martens M, Brazauskas R, Zhu X, Adekola K, Aljurf M, Artz A, Bajel A, Ballen K, Battiwalla M, Beitinjaneh A, Cahn J-Y, Carabasi M, Chen Y-B, Saurabh C, Ciurea S, Copelan E, D'Souza A, Edwards J, Freytes C, Fung H, Gale RP, Giralt S, Hashmi S, Hematti P, Hildebrandt G, Ho V, Jakubowski A, Lazarun H, Mccarthy P, Olin R, Olsson R, Rezvani A, Rizzieri D, Seftel D, Seo D, Sorror M, Szer J, Wood W Increasing Use of Allogeneic Hematopoietic Cell Transplantation (HCT) in Patients Age 70 Years and Older: A CIBMTR Study of Trends and Outcomes. Poster presentation at the Annual BMT Tandem Meetings 2016, Biol Blood and Marrow Transpl. 2016;22(3)Supplement:S68-S69.
36. Thompson J, Drobyski W, D'Souza A, Fenske T, Hamadani M, Hari P, Pasquini M, Saber W, Rizzo D. Etanercept for Late Onset Idiopathic Pneumonia Syndrome. Poster presentation at the Annual BMT Tandem Meetings 2016, Biol Blood and Marrow Transpl 2016;22(3)Supplement:S359
37. Cornell F, Bachanova V, D'Souza A, Ahn KW, Huang J, Krishnan A, Gasparetto C, Nieto Y, Mark T, Hari P. Outcomes after Allogeneic Transplant for Lymphoplasmacytic Lymphoma/Waldenstron Macroglobulinemia: A Center for International Blood and Marrow Transplant Research. Poster presentation at the Annual BMT Tandem Meetings 2016, Biol Blood Marrow Transplant. 2016;22(3)Supplement:S219
38. D’Souza A, Pasquini M, Hari P, Jacobson K, Jacobs P, Flynn K. Patient-reported outcomes in light chain amyloidosis: choosing the optimal tool. Poster presentation at the HealthMeasures User Workshop, Chicago, IL 05/2016 and at the International Symposium on Amyloidosis 07/2016 (Awarded Travel Grant).
39. Hammons L, Brazauskas R, Hari P, Arce-Lara C, Pasquini M, D’Souza A. Abnormal molecular markers are associated with clonal plasma cell burden in light chain amyloidosis. Poster presentation at the American Society of Clinical Oncology Annual Meeting, June 2016.
40. Voshtina E, Szabo A, Hamadani M, Fenske T, D’Souza A, Saber W, Drobyski W, Hari P, Shah N. Impact of Obesity on Outcomes of Elderly Patients Undergoing Allogeneic Hematopoietic Cell Transplant for Myeloid Malignancies. Poster presentation at 58th Annual Meeting of the American Society of Hematology, Blood 2016.
41. Dhakal B, D’Souza A, Zhang MJ, Hamadani M, Hari P. Autologous Hematopoietic Cell Transplantation in Patients with Multiple Myeloma: IMPACT of Age. Poster presentation at 58th Annual Meeting of the American Society of Hematology, Blood 2016.
42. Abidi M, Stoll C, D’Souza A, Pasquini M, Saber W, Fenske T, Rizzo JD, Drobyski W, Keever-Taylor C, Hari P. Importance of Site Preparation in Reducing the Risk of Bacterial Contamination during Bone Marrow Harvest. Poster presentation at the 2017 BMT Tandem Meetings, BBMT 2017.
43. Hari P, Dhakal B, D’Souza A, Thompson R, Hamadani M, Pasquini M, Chhabra S. Pharmacokinetics of Propylene Glycol-Free Melphalan HCl in Multiple Myeloma Patients Undergoing Autologous Transplantation. Poster presentation at the 2017 European Hematologic Association Meeting. Haematologica 2017;102:621.
44. Dhakal B, Chhabra S, Hamadani M, D’Souza A, Usmani S, Jackson J, Hari P. Autologous stem cell transplant (ASCT) for newly diagnosed multiple myeloma (MM) in the era of novel agents: A meta-analysis of phase III randomized clinical trials. Poster presentation at the 2017 ASCO Annual Meeting.
45. Dhakal B, D’Souza A, Hamadani M, Arce-Lara C, Schroeder K, Gauger K, Crone K, Pasquini M, Chhabra S, Hari P. Bendamustine with ixazomib and dexamethasone (BID) for double refractory relapsed multiple myeloma: Phase I safety and dosing results. Poster presentation with discussion at the 2017 ASCO Annual Meeting. J Clin Oncol. 2017;35 (15_suppl):8012.
46. Patel G, Hari P, Szabo A, Rein L, Baumann Kreuziger L, Chhabra S, Dhakal B, D’Souza A. Acquired Factor X Deficiency in Light Chain (AL) Amyloidosis Is Rare and Associated with Advanced Disease. Poster presentation at 59th Annual Meeting of the American Society of Hematology, Blood 2017. (Ms. Patel received a 2017 ASH Abstract Achievement Award).
47. D’Souza A, Millard H, Knight J, Brazauskas R, Flynn K, Lee SJ, Horowitz M, Rizzo D, Shaw B. Patient-Reported Sleep Quality at Baseline Correlates with 1-Year Survival after Allogeneic Hematopoietic Cell Transplantation in Adults. Poster presentation at 59th Annual Meeting of the American Society of Hematology, Blood 2017.
48. Scott E, Hari P, Kumar S, Fraser R, Davila O, Nieto Y, Mark T, Kumar S, Gasparetto C, D’Souza A. A Comparison Between 3 Staging Systems in Multiple Myeloma Using the Center for International Blood and Marrow Transplant Research (CIBMTR) Database. Poster presentation at 59th Annual Meeting of the American Society of Hematology, Blood 2017.
49. Kumar S, D’Souza A, Scott E, Fraser R, Davila O, Gasparetto C, Kumar S, Mark T, Nieto Y, Hari P. Revised-International Staging System (R-ISS) Is Independently Predictive and Prognostic for Early Relapse (<24 months) after Upfront Autologous Hematopoietic Cell Transplantation (AHCT) for Newly Diagnosed Multiple Myeloma (MM). Poster presentation at 59th Annual Meeting of the American Society of Hematology, Blood 2017.
50. Chhabra S, Hari P, Visotcky, Shah N, Rizzo D, Saber W, D’Souza A, Dhakal B, Anshu A, Thompson R, Fenske T, Shaw B, Drobyski W, Pasquini M, Hamadani M. Ixazomib for Chronic Graft-Versus-Host Disease (cGVHD) Prophylaxis in Patients Undergoing Allogeneic Transplantation (alloHCT): Preliminary Results of a Phase I/II Study. Poster presentation at 59th Annual Meeting of the American Society of Hematology, Blood 2017.
51. Dhakal B, Narra R, Smunt T, Canadeo A, Chhabra S, D’Souza A, Gyawali B, Hari P, Niraula S. Incremental Financial and Health-Related Burden of Novel Drugs Used in the Treatment of Relapsed and/or Refractory Multiple Myeloma (RRMM): A Meta-Analysis of Phase III Randomized Controlled Trials (RCTs) Poster presentation at 59th Annual Meeting of the American Society of Hematology, Blood 2017.
52. Dhakal B, Qi X, Guru Murthy, GS, Narra R, Szabo A, Chhabra S, D’Souza A, Hari P. Using “Big-Data” to Evaluate in-Hospital Morbidity and Mortality in Systemic Light Chain (AL) Amyloidosis after High Dose Therapy and Autologous Stem Cell Transplant (HDT/ASCT) Poster presentation at 59th Annual Meeting of the American Society of Hematology, Blood 2017.
53. Badar T, Hari P, Chhabra S, Dhakal B, Drobyski W, Fenske T, Hamadani M, Pasquini M, Saber N, Shah NN, Shaw B, D’Souza A. Use of Propylene Glycol-Free Melphalan Conditioning in Light Chain Amyloidosis Patients Undergoing Autologous Hematopoietic Cell Transplantation is Associated with Significantly Lower Hospitalization Days. Poster presentation at the 2018 BMT Tandem Meetings, BBMT 2018.
54. Knight JM, Rizzo JD, Hari P, Kerswill S, D’Souza A, Logan BR, Hamadani M, Chhabra S, Dhakal B, Shah N, Cole SW. Propranolol inhibits stress-related gene expression profiles associated with adverse clinical outcomes in autologous hematopoietic cell transplantation recipients. Poster presentation at the 2018 BMT Tandem Meetings, BBMT 2018.
55. Knight JM, Costanzo ES, Singh S, Yin Z, Szabo A, Hillard CJ, Rizzo JD, D’Souza A, Coe CL, Drobyski WR. Pre-transplant tocilizumab is associated with more severe depression, anxiety, pain, and sleep following allogeneic hematopoietic cell transplantation. Poster presentation at the 2018 BMT Tandem Meetings, BBMT 2018.
56. Wright N, Flynn KE, Brazauskas R, Hari P, D’Souza A. Patient-reported distress if prevalent in systemic light chain amyloidosis but not determined by severity of disease. Poster presentation at XVIth International Symposium on Amyloidosis, Kumamoto, Japan, Amyloid 2018.
57. Kilari D, Hari P, Qayed M, Fraser R, Davila O, Kumar S, Mark T, Nieto Y, D’Souza A. Improved Outcomes with Tandem Autologous Hematopoietic Cell Transplantation (AutoHCT) Compared to Single AutoHCT for Relapsed/Refractory Germ Cell Tumors: A Center for International Blood and Marrow Transplant Research Study. Poster presentation at Annual Genitourinary ASCO Meeting, February 2018.
 
Non-Peer Reviewed Educational Products
1. Complexities in the Diagnosis and Management of Amyloidosis. 07/10/2016 http://www.ascopost.com/issues/july-10-2016/complexities-in-the-diagnosis-and-management-of-amyloidosis/ Invited educational case-based study with expert opinion in the ASCO Post
 

jenkins-FCD Prod-482 91ad8a360b6da540234915ea01ff80e38bfdb40a